What can ₹2,000 a month do if you invest it in a small-cap mutual fund for the long term? This is an important question for investors who want to start their investment journey with a small amount but build meaningful wealth over time. In this detailed review, we analyse Nippon India Small Cap Fund and
What can ₹2,000 a month do if you invest it in a smallcap mutual fund for the long term? Read More »
JioBlackRock Flexi Cap Fund Review 2026: NAV, Portfolio, SIP, Risk, Returns & Expert Analysis JioBlackRock Flexi Cap Fund Review 2026: Should You Invest? India’s mutual fund industry is evolving rapidly, and one of the biggest recent developments is the launch of JioBlackRock Mutual Fund. Backed by Jio Financial Services and global asset management leader BlackRock,
Axis Multicap Fund Review 2026: ₹10,000 SIP Becomes ₹4.28 Lakh in 3 Years—Should You Invest? Axis Multicap Fund has attracted the attention of mutual fund investors after delivering strong returns over the last three years. According to the latest available fund data, a monthly SIP of ₹10,000 in the scheme grew to approximately ₹4.28 lakh
Axis Multicap Fund Review 2026: SIP, Returns & Portfolio Read More »
SBI Multicap Fund – Regular Plan Growth: Latest Details Fund Name: SBI Multicap Fund Plan: Regular Plan Option: Growth Latest NAV: ₹16.4764 NAV Date: 16 October 2026 Daily NAV Change: +₹0.05 (+0.29%) AUM: Approximately ₹23,455.66 crore as reported for September 2026 Expense Ratio: 1.87% (reported 29 September 2026; verify the latest rate) Benchmark: NIFTY 500
SBI Multicap Fund Regular Growth NAV, Returns & SIP Read More »
Updated: August 2026 | Author: FinancialRelease Research Team Looking for a safer alternative to equity mutual funds without completely giving up the potential to earn market-linked returns? SBI Debt Mutual Funds offer investors access to professionally managed portfolios that invest primarily in fixed-income securities such as Government Securities (G-Secs), Treasury Bills, Corporate Bonds, Certificates
SBI Debt Mutual Funds 2026: Types, Returns & Risks Read More »
Updated: 18 August 2026SBI Arbitrage Opportunities Fund is an arbitrage-oriented hybrid mutual fund designed to seek returns from price differences between the cash and derivatives markets while maintaining a relatively low-risk profile compared with conventional equity funds. But is an arbitrage fund suitable for your short-term money? Can it be an alternative to a savings
SBI Arbitrage Opportunities Fund Returns, NAV, AUM, SIP & Tax in 2026 Read More »
Large cap mutual funds remain one of the most popular investment categories for Indian investors seeking long-term wealth creation with relatively lower volatility than mid-cap and small-cap funds. These funds invest primarily in India’s top 100 listed companies by market capitalization, providing exposure to established businesses with strong balance sheets and market leadership. In this
Best Large Cap Mutual Funds India 2026: Top SIP Funds Read More »
Axis Large Cap Fund Review 2026: Latest Returns, Portfolio, SIP Calculator & ROI Example Note: In 2025, Axis Bluechip Fund was renamed to Axis Large Cap Fund. The investment strategy remains focused on investing predominantly in India’s top 100 listed companies. (The Economic Times) Axis Large Cap Fund – Overview Axis Large Cap Fund is
Axis Bluechip Fund Regular Growth Plan Review 2026 Returns, CAGR, SIP Read More »
Nippon India Large Cap Fund Regular Plan – Complete 2026 Guide for Smart Investors If you are looking for a stable equity mutual fund with exposure to India’s top companies, the Nippon India Large Cap Fund Regular Plan is one of the popular choices among long-term investors. This large-cap mutual fund primarily invests in well-established
Nippon India Large Cap Fund Regular Plan Review 2026 Returns, NAV & SIP Guide Read More »
Aditya Birla Sun Life Mutual Fund offers the Aditya Birla Sun Life Pharma & Healthcare Fund Direct-Growth, a sectoral-pharmacy mutual fund scheme. This fund was launched on June 20, 2019, and has been in operation for five and a half years. As of September 30, 2024, the fund has ₹854 crores in assets under management
Aditya Birla Sun Life Pharma & Healthcare Fund Review 2026: High Return or High Risk? Read More »
टिप्पणी पोस्ट करने के लिए आपको लॉग इन करना होगा।